These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 37587203)
1. Tetraspanins predict the prognosis and characterize the tumor immune microenvironment of glioblastoma. Li YC; Wu Y; Chen G; Zhu LZ; Luo X; Nie QQ; Zhang L; Zuo CJ Sci Rep; 2023 Aug; 13(1):13317. PubMed ID: 37587203 [TBL] [Abstract][Full Text] [Related]
2. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
3. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas. Tian QS; Zhang Q; Huang W Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806 [TBL] [Abstract][Full Text] [Related]
4. A new prognostic model for glioblastoma multiforme based on coagulation-related genes. Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372 [TBL] [Abstract][Full Text] [Related]
5. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers]. Liu J; Xu K; Ma L; Wang Y Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410 [TBL] [Abstract][Full Text] [Related]
6. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing. Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991 [TBL] [Abstract][Full Text] [Related]
7. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway. Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571 [TBL] [Abstract][Full Text] [Related]
8. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis. Zhang H; Bao M; Liao D; Zhang Z; Tian Z; Yang E; Luo P; Jiang X Med Oncol; 2023 Apr; 40(6):161. PubMed ID: 37099121 [TBL] [Abstract][Full Text] [Related]
9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
10. Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma. Dai L; Zhou P; Lyu L; Jiang S BMC Cancer; 2023 Dec; 23(1):1249. PubMed ID: 38114959 [TBL] [Abstract][Full Text] [Related]
11. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma. Zhang W; Li L; Bian PP; Luo QP; Xiong ZT Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030 [TBL] [Abstract][Full Text] [Related]
12. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion Yuan GQ; Zhang G; Nie Q; Wang Z; Gao HZ; Jin GS; Zheng ZQ PeerJ; 2024; 12():e17579. PubMed ID: 38978755 [TBL] [Abstract][Full Text] [Related]
14. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma. Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165 [TBL] [Abstract][Full Text] [Related]
15. A Prognostic Microenvironment-Related Immune Signature Qiu H; Li Y; Cheng S; Li J; He C; Li J Front Oncol; 2020; 10():580263. PubMed ID: 33425732 [TBL] [Abstract][Full Text] [Related]
16. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma. Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L Front Oncol; 2022; 12():1004324. PubMed ID: 36465369 [TBL] [Abstract][Full Text] [Related]
17. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway. Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945 [TBL] [Abstract][Full Text] [Related]
18. The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis. Zhang S; Guo Y; Hu Y; Gao X; Bai F; Ding Q; Hou K; Wang Z; Sun X; Zhao H; Qu Z; Xu Q Front Immunol; 2023; 14():1242972. PubMed ID: 37809064 [TBL] [Abstract][Full Text] [Related]
19. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
20. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme. Sun G; Liu W Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]